CERSCERUS CORP

Nasdaq cerus.com


$ 1.78 $ 0.05 (2.87 %)    

Wednesday, 27-Mar-2024 15:59:58 EDT
QQQ $ 444.97 $ 1.51 (0.34 %)
DIA $ 397.57 $ 4.71 (1.2 %)
SPY $ 523.27 $ 4.36 (0.84 %)
TLT $ 94.66 $ 0.93 (0.99 %)
GLD $ 203.04 $ 1.46 (0.72 %)
$ 1.79
$ 1.79
$ 0.00 x 0
$ 0.00 x 0
$ 1.74 - $ 1.79
$ 1.21 - $ 3.08
1,235,628
na
322.68M
$ 1.56
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-05-2024 12-31-2023 10-K
2 11-02-2023 09-30-2023 10-Q
3 08-03-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 03-01-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 02-22-2022 12-31-2021 10-K
10 11-02-2021 09-30-2021 10-Q
11 08-03-2021 06-30-2021 10-Q
12 05-04-2021 03-31-2021 10-Q
13 02-25-2021 12-31-2020 10-K
14 10-29-2020 09-30-2020 10-Q
15 08-05-2020 06-30-2020 10-Q
16 05-05-2020 03-31-2020 10-Q
17 02-21-2020 12-31-2019 10-K
18 10-30-2019 09-30-2019 10-Q
19 08-01-2019 06-30-2019 10-Q
20 05-07-2019 03-31-2019 10-Q
21 02-27-2019 12-31-2018 10-K
22 11-01-2018 09-30-2018 10-Q
23 08-02-2018 06-30-2018 10-Q
24 05-08-2018 03-31-2018 10-Q
25 03-08-2018 12-31-2017 10-K
26 11-03-2017 09-30-2017 10-Q
27 08-04-2017 06-30-2017 10-Q
28 05-04-2017 03-31-2017 10-Q
29 03-08-2017 12-31-2016 10-K
30 11-04-2016 09-30-2016 10-Q
31 08-05-2016 06-30-2016 10-Q
32 05-06-2016 03-31-2016 10-Q
33 03-09-2016 12-31-2015 10-K
34 11-06-2015 09-30-2015 10-Q
35 08-07-2015 06-30-2015 10-Q
36 05-08-2015 03-31-2015 10-Q
37 03-16-2015 12-31-2014 10-K
38 11-07-2014 09-30-2014 10-Q
39 08-08-2014 06-30-2014 10-Q
40 05-12-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cerus-corporation-announces-fda-approval-of-extended-shelf-life-for-intercept-platelet-processing-sets-doubling-previous-shelf-life

Cerus Corporation (NASDAQ:CERS) today announced that the U.S. Food and Drug Administration (FDA) has granted approval of 12-mon...

 cathie-woods-ark-invest-sells-another-tranche-of-block-shares-even-as-bitcoin-price-stages-a-recovery

On Wednesday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Block Inc (NYSE:SQ) amidst Bitcoin (CR...

 why-blood-components-focused-cerus-stock-is-rising-tuesday

Cerus reports results from the ReCePI Phase 3 trial for INTERCEPT Red Blood Cells, meeting the primary efficacy endpoint in car...

Core News & Articles
Market-Moving News for March 19th
03/19/2024 12:41:16

CERS: 64% | Cerus Corporation Announces Its ReCePI Phase 3 Trial Of INTERCEPT Blood System Met Its Primary Efficacy Endpoint; S...

 cathie-woods-ark-invest-sells-coinbase-shares-as-bitcoin-hits-yet-another-all-time-new-high-buys-stock-of-this-social-media-company

On Wednesday, Cathie Wood-led Ark Invest made significant trades involving Coinbase Global Inc (NASDAQ:COIN) and Pinterest Inc ...

 stephens--co-reiterates-equal-weight-on-cerus-maintains-25-price-target

Stephens & Co. analyst Jacob Johnson reiterates Cerus (NASDAQ:CERS) with a Equal-Weight and maintains $2.5 price target.

 why-united-natural-foods-shares-are-trading-lower-by-15-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.

 cantor-fitzgerald-reiterates-overweight-on-cerus-maintains-3-price-target

Cantor Fitzgerald analyst Ross Osborn reiterates Cerus (NASDAQ:CERS) with a Overweight and maintains $3 price target.

 box-reports-upbeat-earnings-joins-american-public-education-wave-life-sciences-and-other-big-stocks-moving-higher-on-wednesday

U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday.

 cerus-q4-earnings-insights
Cerus: Q4 Earnings Insights
03/05/2024 21:20:06

 cerus-q4-2023-gaap-eps-0010-beats-0020-estimate-sales-46768m-miss-49267m-estimate

Cerus (NASDAQ:CERS) reported quarterly losses of $(0.010) per share which beat the analyst consensus estimate of $(0.020) by 50...

 earnings-scheduled-for-march-5-2024

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2...

 ceruss-earnings-a-preview
Cerus's Earnings: A Preview
03/04/2024 15:02:16

 ge-healthcare-technologies-posts-upbeat-earnings-joins-toyota-spotify-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks traded mostly higher, with the Dow Jones gaining around 70 points on Tuesday.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION